Macromoltek
ActiveAI-nativeComputational antibody design
What it does
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Its site says now · captured 2026-08-23
Macromoltek - Revolutionizing Antibody Design
We use AI and computational modeling to design advanced antibodies, helping biotech and pharma partners accelerate innovation and improve therapeutic outcomes.
Next to it in Healthcare and bio · AI-powered antibody design platform
- Lucidact500 Global 500G GA 25
Developer of an enterprise platform intended to expedite healthcare management. The company's platform leverages artificial intelligence to offer chronic care management, insurance checklist automation, and remote patient tracking management, enabling healthcare professionals to manage more patients and facilitate their operations.
- BeWell DigitalY Combinator W21
Building the operating system for diagnosis.
- Numerion LabsY Combinator W15
Artificial intelligence for drug discovery.
- MedicaiPlug and Play
Medicai is the online medical imaging platform.
- TesaraktSOSV SOSV IndieBio NY 04
Reinventing Brain Care Through AI
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- Lena HealthTechstars TS 2019
Lena | Human Care Navigation, Scaled by AI
- AlgoSurg IncY Combinator W18
We make AI technology for Robotic and AR Surgeries